Outbreaks of myxomatosis in Egyptian domestic rabbit farms by Salem, H. M. et al.
World Rabbit Sci. 27: 85-91 85
OUTBREAKS OF MYXOMATOSIS IN EGYPTIAN DOMESTIC RABBIT FARMS 
SALEM H.M.*, MORSY E.A.*, HASSANEN E.I.†, SHEHATA A.A.‡
*Department of Poultry diseases, Faculty of Veterinary Medicine, Cairo University, P.O. Box 12211, Giza, Egypt.
†Department of Pathology, Faculty of Veterinary Medicine, Cairo University, P.O. Box 12211, Giza, Egypt.
‡Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, University of Sadat City, Sadat City, Egypt.
Abstract: Myxomatosis is an endemic infectious, severe and often fatal disease of rabbit caused by myxoma 
virus. In the present study, myxomatosis outbreaks were reported in 7 domestic rabbit farms in Egypt. 
Rabbits showed oedema of the eyelids, facial oedema and blepharoconjunctivitis. The morbidity and lethality 
rates were 18-100% and 20-80%, respectively. The myxomatosis diagnosis was based on histopathology, 
virus isolation on rabbit kidney cell line (RK-13), polymerase chain reaction (PCR) and sequence analysis. 
Histopathological examination revealed the presence of epidermal hyperplasia, dermal necrosis and 
intracytoplasmic eosinophilic inclusion bodies. The virus was isolated on RK-13 cells and induced cytopathic 
effect. Using PCR, a band of 471 base pair corresponding to the M071L gene was amplified from extracted 
DNA. Sequence alignment of four out of the 7 isolates revealed that these isolates were 98-99% identical to 
European and Australian rabbit myxoma reference viruses. In conclusion, rabbit myxomatosis outbreaks and 
virus isolation procedures are reported herein for the first time in Egypt. Preventive policies against disease 
circulation should be adopted by the national authorities.
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INTRODUCTION
Rabbit myxomatosis is a worldwide distributed enzootic disease of wild and domestic rabbits. The disease is caused by 
rabbit myxoma virus (MYXV), which belongs to family Poxviridae; subfamily Chordopoxvirinae; genus Leporipoxvirus. 
The genus Leporipoxvirus includes four viruses, namely MYXV, hare fibroma virus, squirrel fibroma virus and Shope 
fibroma virus. The 4 viruses are genetically and antigenically related (Cameron et al., 1999, Willer et al., 1999). Like 
other poxviruses, MYXV has a classic large brick-shaped virion, enveloped, double stranded linear DNA genome 
of 163 kilobases (kb) which encode 171 unique genes and are flanked by terminal inverted repeats. The MYXV 
replicates in the cytoplasm of the infected cells, where a wide range of immunomodulatory proteins that play a role in 
viral pathogenesis immune-evasion are elaborated (Kerr and McFadden 2002, Moss et al., 2001). 
Two clinical forms of rabbit myxomatosis have been described; a classic form (myxomatosis, nodular or typical form) 
and an atypical form (amyxomatous form). The classical form is often fatal and characterised by skin pseudotumours 
(myxomas) and swelling of the muzzle, anogenital region and blepharoconjunctivitis, while the atypical or amyxomatous 
form shows variable degrees of severity (Moss et al., 2001, Bertagnoli and Marchandeau, 2015). The high mortality 
rates (usually 10-14  d post infection) are due to multi-organ dysfunction, progressive conjunctivitis and severe 
immunosuppression in which the disease is accompanied by secondary bacterial infection (Fenner, 2000). The virus 
is passively transmitted (mechanical) by biting arthropods such as mosquitoes and fleas (Grodhaus et al., 1963, 
Brugman et al., 2015, Dalton et al., 2015).
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Nowadays, MYXV is endemic in North and South America, Europe and Australia. However, in Egypt there are no 
available data on the presence of the disease. This study reports rabbit myxomatosis outbreaks for the first time in 
the country.
MATERIALS AND METHODS
History of rabbits and sampling
Seven outbreaks of rabbit myxomatosis were recorded in 5 Governorates (Qalyoubia, Behira, Alexandria, Shraqia and 
Giza) in Egypt between autumn 2016 and spring 2017. Clinical disease was observed in rabbits 70-90 d old, with 
high mortality rates in some farms. The background information on these farms including the age, breed and signs 
of the disease, morbidity and mortality rates, and previous vaccination was collected during autumn 2016 and spring 
2017 (Table 1), this period is the most favourable for mosquitoes spreading in Egypt. Freshly dead animals were 
examined for post-mortem lesions and samples (skin lesions, parenchymatous organs) were collected from all farms 
for histopathology and virus isolation. Tissue specimens from skin and different organs were fixed in 10% neutral 
buffer formalin (pH 7.0) to be used for histopathological examination.
Histopathological study
Tissue specimens from skin and different organs (liver, spleen, heart & caecal tonsil) were taken from rabbits and fixed 
in 10% neutral buffer formalin (pH 7.0). The specimens were trimmed and processed by conventional method using 
ascending grade of alcohol. Cutting at 4.5 μm was performed to obtain paraffin sections stained by haemotoxylin and 
eosin (H&E) for histopathological examinations.
Virus isolation
Virus isolation was performed on rabbit kidney (RK-13) monolayer cells grown in cell growth medium (CGM) containing 
Eagle’s minimum essential medium (MEM, Gibco Invitrogen Corporation) and supplemented with 100 UI/mL penicillin, 
60 µg/mL streptomycin, 50 μg/mL gentamicin and 10% foetal calf serum (FCS, Gibco Invitrogen Corporation). Samples 
(samples of 5 rabbits of skin lesions, parenchymatous organs/outbreak) were filtered using 0.45 µm bacteriological filters, 
inoculated onto the confluent RK-13 monolayer in 25 cm2 flasks (NUNC™, Denmark) and incubated 1 h at 37°C for 
adsorption. Subsequently, the inoculums were removed and the infection media (MEM, 2% FCS) was added. Cells were 
incubated at 37°C in an atmosphere of 5% CO2 for 7 d and examined daily for the presence of cytopathic effect (CPE). In the 
absence of CPE, a second blind passage was performed. For identification of the isolated viruses, polimerase chain reaction 
(PCR) was done on harvested cell culture supernatants (2nd and 4th passages) as described below.
Table 1: The evolution of outbreaks.
Sample 
no. Location Breed Age/day Morbidity% Lethality% season Vaccination schedule
1 Qalyoubia Californian and 
New-Zealand
70 100 80 Spring 
2017
Pasteurella, RHDV, Rota, 
E. coli and Clostridiium sp.
2 Qalyoubia New-Zealand 75 50 40 Spring 
2017
Pasteurella, RHDV
3 Behira New-Zealand 80 20 20 Spring 
2017
Pasteurella, RHDV
4 Alexandria Chinchilla and 
New-Zealand
86 45 35 Autumn  
2016
Pasteurella, RHDV
5 Sharqia New-Zealand 90 22 28 Autumn 
2016
Pasteurella, RHDV
6 Giza Flemish and 
Baladi
90 18 30 Autumn 
2016
Pasteurella, RHDV
7 Giza Bouscat and 
New-Zealand
90 23 35 Autumn 
2016
Pasteurella, RHDV
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PCR 
DNA was extracted from harvested samples (5 pooled samples from skin lesions, parenchymatous organs/outbreak) 
using a DNA extraction kit (QIAGEN GmbH, Hilden, Germany) according to the manufacturer’s instructions. PCR 
was performed to amplify a 471 base pair (bp) of M071L gene using M071-F (5’-ACC-CGC-CAA-GAA-CCA-CAG-
TAG-T-3’: location 67 229 nt-67 250 nt) and M071-R (5’-TAA-CGC-GAG-GAA-TAT-CCT-GTA-CCA-3’; location 67 700 
nt-67,677 nt) as forward and reverse primers (Metabion International AG, Planegg, Germany), respectively (Cavadini 
et al., 2010). Briefly, 4 µL of DNA of field samples and negative controls were added to 25 µL of 2× master mix, 1 µL 
of each primer (20 pmol/µL), 1 µL DNA polymerase (Bioline, Luckenwalde Germany) and 18 µL of distilled water. The 
cycler setting was 95°C/3 min; 40× (95°C/30 s, 55°C/30 s, 72°C/50 s) and 72°C/5 min. The PCR product was 
analysed on an agarose gel (1.5%) by electrophoresis and visualised using a UV transilluminator.
Sequencing and sequence analysis
Nucleotide sequencing was done on randomly selected four out of seven isolates, respectively designated MYX 
ME/4, MYX ME/5, MYX ME/6 and MYX ME/7 using the Rhodamine Dye-Terminator Cycle Sequencing Kit 
(Big DyeTerminator v1.1; Applied Biosystems), followed by analysis in an ABIPRISM TM310 Genetic Analyzer (Applied 
Biosystems). Sequences were edited using EditSeq (DNASTAR Inc., Madison, WI, USA). For generation of phylogenetic 
trees, additional rabbit MYXV sequences in GenBank were retrieved. The maximum likelihood method based on the 
Tamura–Nei model was used for evolutionary history and the tree was presented with the highest log likelihood. 
Sequence alignments and phylogenetic tree were performed using MEGA5. 
RESULTS
History, clinical signs and post-mortem lesions
Clinical disease was observed in 6 different rabbit breeds, namely Californian, New Zealand, Chinchilla, Flemish, 
Baladi and Bouscat at 70-90 d of age. Facial lesions were evident in rabbits from all investigated farms. The most 
prominent lesions observed were oedema, eyelid erythema, facial myxomas and blepharoconjunctivitis and, in some 
Figure 1: Clinical picture of rabbit myxomatosis. Rabbits showing oedematous swelling of upper eye lid (A), 
conjunctivitis with lacrimation (B) and myxomas extended from upper lip, localized pseudo tumour over growth 
covered by crusts (C).
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Figure 2: Histopathologic examination of skin and visceral organs of rabbits suffered from myxomatosis: (A) Epidermal 
hyperplasia (arrows) with vacuolar degeneration in spinous cell layer (H&E 200×). (B) Epidermal hyperplasia and 
vacuolar degeneration with presence of intracytoplasmic eosinophilic inclusion bodies (arrows) (H&E 200×). (C) 
Fibroblast proliferation with mild mononuclear inflammatory cells (arrow) infiltration in the dermis (H&E 400×). (D) 
Stellate, spindle cells (arrows) in abundant mucinous matrix in the dermis with moderate mononuclear cells (star) 
infiltrations (H&E 400×). (E) Pleomorphic cells (arrow) in abundant myxoedematous materials (star) with fibroblast 
cells in the dermis in addition to moderate haemorrhage (H&E 400×). (F) Epidermal hyperplasia (arrow), dermal 
myxomatosis (arrow head) with hyalinosis (star) of the dermal connective tissue (H&E 200×). (G) Heart showing 
degeneration and necrosis of cardiac muscle with extensive haemorrhage in between (H&E 200×). (H) Cecal tonsil 
showing destruction of lymphocytes in lymphoid follicles and lymphoid depletion with presence of tangible body 
macrophages (arrows) (H&E 200×).
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cases, the cutaneous lesions extended from the skin covering the nose. The skin of most cases presented localised 
overgrowth or pseudo-tumour mass covered with crusts. Ocular and nasal discharges were also observed in some 
cases (Figure 1). Rabbits also showed depression, anorexia and severe emaciation. Post-mortem lesions revealed 
congestion and haemorrhages in the internal organs. Morbidity rates ranged between 18-100%, while the lethality 
rates varied from 20-80% (Table 1) during the observation period (4 wk after emergence of outbreaks). Stamping-out 
policy was not adopted, and only symptomatic treatment was applied to control the disease. All the examined farms 
had a history of vaccination against Pasteurellosis and rabbit haemorrhagic disease (RHD). Rabbits from farm No. 1 
were additionally vaccinated against rotavirus, colibacillosis and clostridiosis. Investigation of the farms revealed that 
all were heavily infested with mosquitoes. 
Histopathological examinations
The most prominent microscopic lesion observed in the skin was epidermal hyperplasia, characterised by 
hyperkeratosis and acanthosis increasing the epidermal layer thickness (Figure 2A). Epidermal cellular swelling and 
vacuolar degeneration was noted in all sections, along with presence of intracytoplasmic eosinophilic inclusions in the 
degenerated cells (Figure 2B). The epidermis and dermis were infiltrated with mononuclear inflammatory cells, mainly 
lymphocytes and plasma cells, as well as a few neutrophils present in addition to proliferation of fibroblast cells in the 
dermal layer (Figure 2C). A particular feature was the presence of stellate, spindle cells with or without intracytoplasmic 
eosinophilic bodies (ICIB) in abundant mucinous matrix in the dermis (Figure 2D, 2E). Dermal necrosis with hyalinosis 
as well as haemorrhage was also recorded in most sections (Figure  2F). Hair follicles showed destruction in its 
epithelial lining, which desquamated into the follicular cavity and mixed with inflammatory cells. Most of the hair 
follicles dilated and blocked by keratin in addition to pre follicular sclerosis and leucocytic cell infiltration, while 
others atrophied with destructed epithelial lining. Muscular layer showed Zenkers necrosis in addition to oedema, 
with severe infiltration of inflammatory cells. Visceral lesions were occasionally observed; necrosis, oedema and 
haemorrhage were detected in lymphoid organs, kidneys, liver, and heart (Figure 2G). There was lymphoid depletion 
in the spleen, caecal tonsils and lymph nodes, with destruction of mature lymphocytes (Figure 2H). Eosinophilic ICIB 
were also observed in the degenerated epithelial cells of the visceral organs. 
Virus isolation 
At the 2nd passage, infected RK-13 cells with isolates No. 1, 2, 3, 4, 5 and 7 showed CPE. However, isolate No. 6 
induced CPE at the 3rd passage. The CPE started with rounding and detachment of cells from the monolayer. Later, 
all cells were affected, and the cell monolayer detached completely (Figure 3). The presence of rabbit MYXV was 
confirmed using PCR performed on second and fourth passages for detection of a 471 bp corresponding to the 
M071L gene (data not shown).
Figure 3: Isolation of rabbit myxoma virus on RK-13 cells. A) RK-13 cells infected with rabbit MYXV field isolate-4 
showing focal rounding and detachment of cells at 4 dpi. B) Monolayer culture of RK-13 cells.
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PCR and sequence analysis
PCR employed on the field samples (samples of 5 rabbits/outbreak) confirmed that all samples were positive for 
rabbit MYXV. All samples showed a band of 471 bp corresponding to the M071L gene. The MYX ME/4, MYX ME/5, 
MYX ME/6 and MYX ME/7 clustered with European and Australian reference strains (Figure 4) and exhibited a high 
identity 98-100% with Cornwall/4-54/1, Lausanne, Nottingham/4-55/, Perthshire-2524, Uriarra and Yorkshire/127, 
SWH 8/2/93, KM13, Bendigo, BRK, Yorkshire KY548813 and 99% with Glenfield. However, the 4 viruses exhibited 
relatively lower homology with Borghi (93-94%) and California/San Francisco (91-92%). The currently isolated viruses 
are 86-87% identical with Rabbit fibroma virus. The MYX viruses are currently clustered with European and Australian 
MYX viruses. The sequences were submitted to the GenBank under accession numbers (MH107056-9).
DISCUSSION
Myxomatosis continued to be endemic in several countries and is still a relevant threat for rabbit industries (Kerr, 
2012; Dalton et al., 2015). However, to date there is no record on the prevalence or distribution of the disease in 
Egypt. In the present study, seven outbreaks of myxomatosis were reported in Egypt for the first time. Clinical disease 
was observed in different rabbit breeds at 70-90 d of age, with variable lethality rates (20-80%). Several factors cause 
variation in the mortality rate, such as farm hygiene, the host immunity, age of infected rabbits, control of arthropods, 
biosecurity measures and the MYXV virulence. Secondary bacterial infections with Pasteurella spp. and Bordetella 
spp. of the conjunctivae, upper respiratory tract, and lungs are typical in rabbits that survive longer than 10-14 d 
after infection and could be the major cause of death in rabbits infected with sub-acute strains of MYXV (Best et al., 
2000; Silvers et al., 2006; OIE, 2017). In our study, symptomatic treatment was adopted to control the disease using 
immune stimulant, antibiotics after sensitivity testing and anti-inflammatory drugs. 
In our study, histopathological examination revealed the presence of severe ulcerative, necrotising dermatitis, ICIB 
in the degenerated cells, and infiltration with mononuclear inflammatory cells which are pathognomonic for MYXV. 
However, microscopic lesions might vary according to the virulence of strains and breeds (Best et al., 2000). The 
origin of the emerged myxomatosis outbreaks in Egypt is still unclear.
Figure 4: Phylogenetic analysis of the isolated rabbit myxoma viruses ME-MYX4, ME-MYX5, ME-MYX6 and ME-
MYX7. The strains isolated in the current study are indicated by a red circle. The reliability of the phylogenetic tree 
was evaluated by bootstrap analysis of 1000 replicates.
Outbreaks Of myxOmatOsis in egyptian dOmestic rabbit farms
World Rabbit Sci. 27: 85-91 91
Sequence analysis of the amplified region of 400 bp of four selected viruses (MYX ME/4, MYX ME/5, MYX ME/6 
and MYX ME/7) revealed 98-100% identity with reference rabbit myxoma viruses. The percentages of homology are 
relative only to the short sequence amplified and sequenced and not to the whole genome. Considering the large 
genomic size and the high number of MYXV proteins expressed, the level of identity with regard to the mentioned 
strains could be indeed much more variable and different. Interestingly, it seems that the 4 detected strains belong 
to 2 different clusters, indicating that the outbreaks might be not originated from a single source, but different 
introduction could be claimed. Further study is urgently needed to understand the molecular epidemiology of the 
disease in Egypt. The introduction of the virus into Egyptian rabbit farms might be through imported rabbits, further 
investigations are required to determine the exact origin of the virus. Hence, vaccination might be a successful way 
to prevent myxomatosis in rabbits (Calvete et al., 2004; Ferreira et al., 2009), and a vaccination scheme should be 
adopted by the rabbit producers, timely informed by the national authority. In addition, other measures such as control 
of biting insects, good hygienic practices and quarantine of introduced rabbits should be taken into consideration.
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